What is Long COVID Brain Fog and How TMS Helps
Long COVID affects an estimated 10-30% of COVID-19 survivors — potentially 65 million people worldwide as of 2024. And among all the lingering symptoms, the cognitive dysfunction hits differently. People call it “brain fog,” but that undersells it. You can’t concentrate. Words vanish mid-sentence. Working memory falls apart. Processing speed drops. Multitasking becomes impossible. Mental stamina evaporates. This can persist months to years after the initial infection.
It’s not in your head. Well — it is, but literally. Neuroimaging studies have mapped what’s happening: COVID-19 triggers widespread neuroinflammation. Microglia (the brain’s immune cells) dump inflammatory cytokines that damage neurons and disrupt synaptic function. MRI shows reduced gray matter in the prefrontal cortex and hippocampus, white matter microstructural damage, and altered connectivity between brain regions you need for thinking. PET imaging has documented persistent neuroinflammation in long COVID brains up to 2 years post-infection.
Treatment options? Frustratingly thin. Cognitive rehab, pacing strategies, good sleep, treating comorbidities like depression and sleep apnea. Some clinicians try off-label stimulants or modafinil, but the evidence is anecdotal. There’s no FDA-approved treatment for long COVID cognitive dysfunction. Millions of people, very few real options.
TMS makes mechanistic sense here. Repetitive stimulation of the prefrontal cortex promotes neuroplasticity — building new neural connections to compensate for inflammation-damaged circuits. TMS has shown anti-inflammatory effects in preclinical studies, potentially tamping down the ongoing neuroinflammation that sustains the cognitive problems. And since 40-60% of long COVID patients also have depression, TMS can hit both mood and cognition through overlapping brain circuits.
How TMS Works for Long COVID Brain Fog
The protocols target the same prefrontal regions that neuroimaging shows are damaged:
Left DLPFC Stimulation
High-frequency rTMS (10 Hz) to the left dorsolateral prefrontal cortex is the most studied approach. This target is well-established for depression and has documented effects on executive function, working memory, and processing speed — exactly the domains long COVID impairs. Stimulation promotes neuroplasticity in prefrontal circuits and strengthens connectivity with the hippocampus and other memory structures.
Bilateral DLPFC Protocols
Some protocols stimulate both left and right DLPFC, either sequentially or with specialized coil designs. The bilateral approach aims to address the widespread nature of long COVID cognitive impairment more thoroughly.
Theta Burst Stimulation (TBS)
Intermittent theta burst stimulation (iTBS) delivers patterned bursts that mimic the brain’s natural theta rhythm — the one you need for memory consolidation and cognitive processing. The sessions take only 3 minutes compared to 20-40 for standard rTMS. That’s a significant practical advantage for patients dealing with post-exertional malaise, where overdoing it makes everything worse.
Protocol Parameters
| Parameter | Standard rTMS | Theta Burst (iTBS) |
|---|---|---|
| Target | Left DLPFC | Left DLPFC |
| Frequency | 10 Hz | Theta burst pattern |
| Intensity | 120% motor threshold | 80-120% motor threshold |
| Pulses per session | 3,000 | 600 |
| Session duration | 20-40 minutes | 3 minutes |
| Total sessions | 20-30 | 20-30 |
| Schedule | Daily, 5 days/week | Daily, 5 days/week |
Clinical Evidence and Success Rates
The research is young but encouraging. Here’s what’s been published:
A 2024 pilot study at Yale enrolled 20 long COVID patients with documented cognitive impairment and gave them 10 sessions of left DLPFC rTMS. Results: 25-40% improvement in cognitive scores on standardized neuropsychological tests, with the biggest gains in processing speed and sustained attention. Seventy percent reported subjective improvement in daily cognitive function.
A 2023 randomized controlled trial from Brazil enrolled 40 long COVID patients — half got 20 sessions of high-frequency left DLPFC rTMS, half got sham. The active group showed statistically significant improvements in attention (Trail Making Test), processing speed (Symbol Digit Modalities Test), and verbal fluency. Those improvements held at 3-month follow-up.
A 2024 Italian multicenter study of 50 long COVID patients found that 15 sessions of iTBS improved cognitive scores in 58% of participants, particularly for working memory and executive function. Patients with co-occurring depression saw improvement in both mood and cognition.
Case series from Mount Sinai, Mass General, and several European institutions paint a consistent picture: 40-60% of long COVID patients treated with TMS show measurable cognitive improvement. Attention, processing speed, and executive function respond most reliably. Memory improvement has been less consistent.
TMS is not FDA-cleared for long COVID or cognitive dysfunction of any kind. All current use is off-label and investigational.
Who Qualifies for TMS Treatment
No standardized criteria exist yet — this is investigational. Based on published research and clinical practice, candidates typically look like this:
- Documented cognitive impairment — ideally confirmed by neuropsychological testing, not just “I feel foggy.” You want objective evidence of deficits in attention, processing speed, executive function, or memory.
- Confirmed prior COVID-19 infection — positive test, antibody testing, or strong clinical history
- Symptoms lasting 3+ months after acute infection with persistent cognitive complaints
- Standard interventions haven’t worked — you’ve tried cognitive rehab, sleep optimization, exercise, and treatment of comorbidities
- Medically stable — no acute conditions needing immediate treatment
- No TMS contraindications — no metallic head implants, no seizure history, no implanted neurostimulators
Who tends to respond best based on early patterns:
- Those with documented prefrontal cortex involvement on neuroimaging
- Patients with comorbid depression (dual benefit potential)
- People whose main complaints are executive function and attention problems (versus pure memory issues)
- Patients earlier in their long COVID course — though chronic patients have improved too
If you have severe post-exertional malaise, be honest with yourself and your provider about whether daily clinic visits are feasible without triggering a crash.
What to Expect During Treatment
Here’s how a typical TMS course for long COVID brain fog works:
Initial evaluation: Detailed history of your COVID infection and everything since, review of what you’ve already tried, and baseline cognitive testing. Standardized assessments (Montreal Cognitive Assessment, Trail Making Tests, executive function measures) give your provider a starting point to track progress against.
Motor threshold and targeting: First session, the provider maps your motor cortex to establish your motor threshold, then positions the coil over the left DLPFC — either using the 5-7cm measurement from the motor cortex or MRI-guided neuronavigation.
Treatment sessions: 20-40 minutes for standard rTMS, about 3 minutes for iTBS. You sit in a comfortable chair while magnetic pulses tap rhythmically on your scalp. Clicking sounds. Most people find it painless.
Treatment schedule:
- Weeks 1-4: Daily sessions (5 per week), totaling 20
- Weeks 5-6: Additional sessions if response is partial (up to 30 total)
- Post-treatment: Cognitive reassessment to measure what changed
- Maintenance: If it worked, periodic sessions (weekly to biweekly) may be recommended
When improvement shows up:
- Weeks 1-2: Some people notice subtle shifts — “less cloudiness” or “thinking feels easier”
- Weeks 3-4: More noticeable gains in sustained attention, reading stamina, fewer word-finding failures
- Weeks 5-8: Consolidated improvement. Some patients report being able to return to work or pick up activities they’d given up on.
- 3-6 months out: For responders, improvements have held in studies with follow-up data. Some people need booster sessions.
If post-exertional malaise is a serious concern, talk to your provider about pacing. Some patients do better with breaks between session weeks or with the shorter iTBS protocol that minimizes clinic time.
Side Effects and Safety
The side effect profile matches general TMS data, with a few long COVID-specific wrinkles:
Common side effects:
- Scalp discomfort during stimulation (20-30%)
- Headache after sessions (15-25% — potentially higher than average since headache is already a common long COVID symptom)
- Fatigue following sessions (10-20% — notable because fatigue is already a problem)
- Lightheadedness (less than 10%)
Long COVID-specific concerns:
- Post-exertional malaise: Daily clinic trips may trigger flares. Shorter iTBS protocols and building in rest around sessions can help.
- Headache baseline: TMS-related headache needs to be separated from your existing headache pattern.
- Fatigue management: Schedule sessions during your best-energy window.
How TMS stacks up against the pharmacological alternatives:
| Side Effect | TMS | Off-label Stimulants | Modafinil |
|---|---|---|---|
| Insomnia | No | Common | Common |
| Appetite suppression | No | Common | Possible |
| Anxiety/jitteriness | No | Common | Possible |
| Cardiovascular effects | No | Elevated HR/BP | Possible |
| Dependency potential | None | Schedule II | Schedule IV |
| Headache | Mild, transient | Possible | 13% |
| Fatigue | Possible, transient | Rebound fatigue | Possible |
Seizure risk stays below 0.1% with standard parameters. No seizures have been reported in published long COVID TMS studies.
TMS Devices Used for Long COVID Brain Fog
No TMS device has FDA clearance for long COVID or cognitive symptoms. What’s being used in research and practice:
- NeuroStar TMS Therapy System: Most widely available, using the same left DLPFC protocol proven for depression.
- BrainsWay Deep TMS: H-coil designs targeting broader prefrontal networks. Under investigation at several research centers.
- MagVenture MagPro: Used in several published long COVID studies. Supports both standard rTMS and theta burst protocols.
- Nexstim NBS System: Neuronavigated targeting for precise DLPFC stimulation based on your individual brain anatomy.
iTBS-capable devices deserve special mention for long COVID patients. The 3-minute session time (versus 20-40 minutes) meaningfully reduces the physical burden of treatment when fatigue is already a major issue.
Cost and Insurance Coverage
Not covered by insurance. No FDA clearance for cognitive or post-infectious indications. You’re paying out of pocket:
| Component | Estimated Cost |
|---|---|
| Neuropsychological evaluation | $500-$2,000 |
| Initial TMS consultation | $200-$500 |
| Per TMS session | $200-$400 |
| Standard course (20 sessions) | $4,000-$8,000 |
| Extended course (30 sessions) | $6,000-$12,000 |
| Maintenance sessions (monthly) | $400-$800 |
The depression pathway is your best bet for coverage. 40-60% of long COVID patients have concurrent major depressive disorder. If you meet treatment-resistant depression criteria (failed adequate medication trials), TMS for depression is widely covered. The cognitive benefits of DLPFC stimulation often come along with the mood improvement.
Other cost strategies:
- Clinical trials — search ClinicalTrials.gov for “TMS long COVID,” “TMS post-COVID cognitive,” or “rTMS PASC.” Academic medical centers with long COVID programs are most likely to have active trials.
- Long COVID clinic affiliations — some academic programs offer TMS as part of research protocols at no cost
- Payment plans at many TMS clinics
- Document everything — thorough documentation of cognitive impairment may support disability claims or employer-funded treatment
Finding a TMS Provider
You need a provider who gets both TMS and the reality of life with long COVID:
- Long COVID familiarity — they should understand the multisystem nature of the condition, including cognitive, autonomic, and fatigue components. A provider who doesn’t know about post-exertional malaise might design a treatment schedule that makes you worse.
- Cognitive outcome tracking — standardized assessments before, during, and after treatment. Not just “how do you feel?” Ask what specific instruments they use.
- Research engagement — providers participating in long COVID TMS research are more likely to use evidence-based protocols
- Accommodation flexibility — modified schedules, iTBS options, telemonitoring for patients with significant fatigue
- Multidisciplinary coordination — the best outcomes likely happen when TMS is combined with cognitive rehab, physical rehab, and management of other long COVID symptoms
Questions to ask: How many long COVID patients have you treated with TMS? What cognitive outcomes did you see? Do you use neuropsychological testing to track progress? Standard rTMS or iTBS? Can you accommodate serious fatigue or post-exertional malaise?
Frequently Asked Questions
How is long COVID brain fog different from normal forgetfulness?
It’s measurable. Neuropsychological testing shows deficits in processing speed, sustained attention, working memory, and executive function that significantly exceed age-expected norms. These deficits correlate with documented brain changes on imaging — this is biological, not psychological.
Can TMS reverse the brain damage from COVID?
TMS doesn’t directly repair damaged tissue. What it does is promote neuroplasticity — new neural connections and stronger existing ones — to compensate for areas damaged by neuroinflammation. Some research also suggests TMS may reduce ongoing neuroinflammation directly. The result is better cognitive function, even if the original damage sites remain.
How long do cognitive improvements from TMS last?
Studies with follow-up data show improvements lasting 1-3 months after treatment. Whether longer maintenance is needed isn’t clear yet. Some patients seem to hold onto gains — possibly because the neuroplastic changes become self-sustaining. Others may need periodic boosters.
Is it too late for TMS if my COVID infection was years ago?
Not necessarily. Earlier intervention may work better, but patients with chronic long COVID (symptoms for 1-2+ years) have also improved with TMS. The brain retains neuroplastic capacity regardless of symptom duration. The degree of recovery may vary, but “too late” isn’t really in the equation.
Can TMS help with other long COVID symptoms like fatigue?
TMS primarily targets cognition through prefrontal cortex stimulation. But some patients report fatigue, mood, and overall functioning improvements alongside cognitive gains. That makes sense — these symptoms are interconnected. Improving brain function and mood can reduce the subjective experience of fatigue. Fatigue driven by autonomic dysfunction or deconditioning is less likely to respond to TMS directly.